SCHEMBL22717860

SCHEMBL22717860

COC(=O)c1cc(C(=O)O)ncc1-c1ccccc1OC

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.54
▸ ASPH Q12797 4/20 0.54
▸ KDM8 Q8N371 4/20 0.54
▸ P4HTM Q9NXG6 1/20 0.46
▸ MAPK1 P28482 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ VDR P11473 1/20 0.44
▸ SLC6A3 Q01959 1/20 0.43
▸ HSP90AA1 P07900 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ RIOX2 Q8IUF8 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ FGFR1 P11362 1/20 0.42
▸ SRC P12931 1/20 0.42
▸ DHODH Q02127 1/20 0.42
▸ HSD17B10 Q99714 2/20 0.42
▸ ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22717397 0.84 POLQ (0.53) KDM4EMAPK1VDRSLC6A3HSP90AA1
SCHEMBL22717423 0.83 SLC6A3 (0.47) KDM4EMAPK1VDRSLC6A3HSP90AA1
SCHEMBL22717267 0.83 ALDH1A1 (0.50) KDM4EMAPK1L3MBTL1VDRSLC6A3
SCHEMBL29574586 0.83 SLC6A3 (0.47) KDM4EMAPK1VDRSLC6A3HSP90AA1
SCHEMBL29575360 0.81 VDR (0.46) KDM4EMAPK1VDRSLC6A3HSP90AA1
SCHEMBL22717582 0.81 VDR (0.46) KDM4EMAPK1VDRSLC6A3HSP90AA1
SCHEMBL25307008 0.80 SDHB (0.46) KDM4EVDRSLC6A3HSP90AA1MAPT
SCHEMBL22717432 0.80 MAPT (0.45) KDM4EMAPK1L3MBTL1VDRSLC6A3
SCHEMBL22717445 0.80 ALDH1A1 (0.47) KDM4EMAPK1VDRHSP90AA1MAPT
SCHEMBL22717528 0.78 VDR (0.43) KDM4EVDRHSP90AA1MAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260049074-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. (US) 2026-02-19 — — US disclosed
US-12509454-B2 Thiadiazolyl derivatives IDEAYA BIOSCIENCES, INC. (US) 2025-12-30 — — US disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
EP-3976608-B1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES INC (US) 2023-11-08 — — EP disclosed
US-20230078112-A1 THIADIAZOLYL DERIVATIVES IDEAYA BIOSCIENCES, INC. 2023-03-16 — — US disclosed
EP-3976608-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS Ideaya Biosciences, Inc. (US) 2022-04-06 — — EP disclosed
CN-114127062-A Thiadiazolyl derivatives as inhibitors of DNA polymerase Theta 伊迪亚生物科学有限公司 2022-03-01 — — CN disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed
WO-2020243459-A1 THIADIAZOLYL DERIVATIVES AS DNA POLYMERASE THETA INHIBITORS IDEAYA BIOSCIENCES, INC. (US) 2020-12-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260049074-A1 THIADIAZOLYL DERIVATIVES POLH, POLM, POLD1 KDM4E 3719/4885ASPH 1718/4885KDM8 1784/4885
US-20230078112-A1 THIADIAZOLYL DERIVATIVES POLQ, POLK, POLA1 KDM4E 3851/4885ASPH 3023/4885KDM8 2803/4885
US-12509454-B2 Thiadiazolyl derivatives POLD1, POLQ, DNA2 KDM4E 3903/4885ASPH 1549/4885KDM8 2567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback